home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9603.zip
/
M9630148.TXT
< prev
next >
Wrap
Text File
|
1996-02-27
|
2KB
|
40 lines
Document 0148
DOCN M9630148
TI Levels of the circulating cell adhesion molecule E-selectin and disease
progression in HIV infection.
DT 9603
AU Sfikakis PP; Tzavara V; Sipsas N; Kosmopoulou O; Sfikakis P; Kordossis
T; First Dept. of Propedeutic Medicine, Athens University Medical;
School, Laikon General Hospital, Greece.
SO Infection. 1995 Jul-Aug;23(4):207-11. Unique Identifier : AIDSLINE
MED/96055298
AB The levels of soluble form of E-Selectin (sEs), or endothelial-leukocyte
adhesion molecule-1, were measured in 96 sera derived from 72
HIV-infected patients at different stages of the disease, 60 healthy
blood donors, and 50 HIV-negative patients with infections, using a
quantitative ELISA. Levels of sEs in HIV-infected individuals without
AIDS, according to the 1993 classification system of the Centers for
Disease Control, were higher than normal (mean +/- SEM 48 +/- 4 versus
35 +/- 3 ng/ml, p = 0.003). Patients with established AIDS, who were
afebrile and had no evidence of acute concurrent infection, had even
higher sEs serum levels (70 +/- 9 ng/ml, p = 0.009, compared to those
without AIDS). A significant increase in clinical category disease
progression was present. Individual concentrations of sEs correlated
directly with levels of soluble intercellular adhesion molecule-1 (p <
0.00001) and IL-2 receptor (p = 0.001), but not with CD4+ T-cell counts.
Zidovudine treatment was not associated with changes in sEs serum
levels. Elevated sEs levels were also found in HIV-seronegative patients
with other bacterial and protozoal infections. Since sEs is a
biologically active molecule, further studies should investigate the
pathogenetic significance of circulating sEs in HIV-related disease
progression, and assess the prognostic value of sEs determination for
these patients.
DE Acquired Immunodeficiency Syndrome/*BLOOD/IMMUNOLOGY Adult Aged
Disease Progression E-Selectin/*BLOOD Female Human HIV
Infections/*BLOOD/IMMUNOLOGY Male Middle Age Support, Non-U.S. Gov't
JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).